111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
View analysts' price targets and recommendations, and compare them with competitors.
$114.00
Lower downside than CX's downside of 16.39%.
Buy
Better than CX's analyst recommendation of Hold.
Analyze analyst forecasts for the company and compare them with competitors.
29.81B
Better than CX's estimated revenue of 13.52B.
4.91B
Better than CX's estimated ebitda of 2.38B.
1.64
Worse than CX's estimated eps of 8.09.
1.19B
Worse than CX's estimated net income of 10.06B.
3.25B
Better than CX's estimated ebit of 1.33B.
6.68B
Worse than CX's estimated sg&a expense of 2.51B.
Analyze DCF forecasts for the company and compare them with competitors.
33.96B
Better than CX's revenue of 771.21M.
5.62%
Worse than CX's revenue growth rate of 7.07%.
5.59B
Better than CX's ebitda of 111.94M.
16.45%
Better than CX's ebitda margin of 14.51%.
3.95B
Better than CX's ebit of 56.49M.
11.63%
Better than CX's ebit margin of 7.32%.
1.64B
Worse than CX's depreciation of 55.45M.
6.16B
Better than CX's total cash of 24.51M.
18.14%
Better than CX's cash as percentage of revenue of 3.18%.
4.46B
Worse than CX's receivables of 90.06M.
13.14%
Worse than CX's receivables as percentage of revenue of 11.68%.
4.35B
Worse than CX's inventories of 82.63M.
12.82%
Worse than CX's inventories as percentage of revenue of 10.71%.
3.04B
Worse than CX's accounts payable of 146.85M.
8.95%
Better than CX's payables as percentage of revenue of 19.04%.
-1.58B
Better than CX's capital expenditure of -52.48M.
-4.65%
Worse than CX's capex as percentage of revenue of -6.80%.
9.66%
Worse than CX's weighted average cost of capital (wacc) of 9.48%.
10.90%
Worse than CX's cost of equity of 9.69%.
4.40%
Better than CX's cost of debt of 7.04%.
1.38
Worse than CX's beta of 1.12.
729.20M
Better than CX's diluted shares outstanding of 1.47B.
13.52B
Worse than CX's total debt of 404.20M.
68.33B
Better than CX's total equity of 8.15B.
81.85B
Better than CX's total capital of 8.55B.
16.51%
Worse than CX's debt weighting of 4.73%.
83.49%
Worse than CX's equity weighting of 95.27%.
3.06B
Better than CX's ebiat of 41.16M.
-1.75B
Worse than CX's unlevered free cash flow of 25.51M.
2.00%
Equal to CX's long-term growth rate of 2.00%.
56.34B
Better than CX's terminal value of 942.19M.
50.70B
Better than CX's enterprise value of 836.08M.
6.94B
Worse than CX's net debt of 373.30M.
43.76B
Better than CX's equity value of 462.78M.
60.01
Better than CX's equity value per share of 0.31.
